Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new internal update; no study information or visible content changes are evident.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s footer “Revision” number is updated from v3.5.2 to v3.5.3, reflecting a minor ClinicalTrials.gov site/version release rather than a change to the study details.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check110 days agoChange DetectedRevision metadata updated from v3.4.1 to v3.4.2. This is a minor metadata update and does not affect the study information.SummaryDifference0.1%

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.